| Public | NASDAQ:PETX |
| Date | 5/13 |
| Raised | $51M |
| Post IPO Valuation | $223M |
| Website | aratanatherapeuti... |
| Category | BioTech |
| Phone | 913-951-2130 |
| Employees |
| TOTAL | $47M |
| FUNDING TOTAL | $47M |
| Series A, 1/11 MPM Capital Avalon Ventures Kansas Bioscience Authority | $20M |
| Series B, 12/11 MPM Capital Avalon Ventures Cultivian Ventures | $15M |
| Series C, 1/13 | $12M |
Aratana Therapeutics, a Kansas City, Kansas-based newly-formed company focused on the development of innovative therapies for the animal health industry.
